TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
3.940
-0.180 (-4.37%)
At close: Nov 21, 2024, 4:00 PM
3.910
-0.030 (-0.76%)
After-hours: Nov 21, 2024, 4:00 PM EST
TScan Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$11.40
Upside
+189.34%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +280.71% | Nov 15, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +179.19% | Nov 12, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +179.19% | Nov 6, 2024 |
Wedbush | Wedbush | Buy Reiterates $10 | Buy | Reiterates | $10 | +153.81% | Aug 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +280.71% | Aug 13, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +179.19% | Aug 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +280.71% | Jun 4, 2024 |
BTIG | BTIG | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +204.57% | May 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +280.71% | May 14, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +179.19% | May 13, 2024 |
Wedbush | Wedbush | Buy Reiterates $10 | Buy | Reiterates | $10 | +153.81% | Apr 23, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +280.71% | Mar 7, 2024 |
Barclays | Barclays | Buy Maintains $7 → $9 | Buy | Maintains | $7 → $9 | +128.43% | Mar 7, 2024 |
Wedbush | Wedbush | Buy Reiterates $9 | Buy | Reiterates | $9 | +128.43% | Feb 1, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +280.71% | Aug 14, 2023 |
Wedbush | Wedbush | Buy Initiates $8 | Buy | Initiates | $8 | +103.05% | Jun 22, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.